Characterization of meningococcal disease outbreaks in the United States, 2014–2019

BACKGROUND: Meningococcal disease, caused by the bacterium Neisseria meningitidis, is a serious bacterial infection that can be fatal or leave survivors with permanent sequelae. Despite decades of declining incidence in the United States (U.S.), meningococcal disease outbreaks are still of public health concern. METHODS: Meningococcal disease cases reported through the National Notifiable Diseases Surveillance System along with additional data provided by jurisdiction health departments were used to identify outbreak-associated cases and public health response measures during 2014-2019. Outbreaks were defined as 2-3 cases within an organization during a 3-month period, an incidence of meningococcal disease above expected in a community during a 3-month period, or ≥2 cases that occurred in the same family or household during a 24-month period. RESULTS: Twenty-nine meningococcal disease outbreaks were reported in the U.S. during 2014-2019 (18 organization, 8 community, 3 household). Outbreak-associated cases (n = 130), accounted for 5.8% of all meningococcal disease cases (n = 2,228) reported during 2014-2019 and were predominantly serogroups B and C. Community outbreaks had longer median durations (203 days) compared to family/household and organization outbreaks (136 days and 9 days, respectively). Of the 7 family/household outbreak-associated cases, only 2 occurred within 14 days of each other. Based on available information for 23 outbreaks, a response measure was implemented in 21 outbreaks: mass vaccination campaign alone (14), expanded chemoprophylaxis alone (2), and both mass vaccination campaign and expanded chemoprophylaxis (5). CONCLUSION: We identified outbreaks of meningococcal disease in a variety of settings and populations; however, this is the first time family/household outbreaks have been systematically characterized in the U.S. Our findings suggest that household contacts of meningococcal disease patients may be at increased disease risk beyond direct secondary transmission. Additional evaluations will be helpful to better assess the potential benefit of vaccination for family members of cases in household settings.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-18
DOI
https://doi.org/10.1371/journal.pone.0362457
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Characterization of meningococcal disease outbreaks in the United States, 2014–2019

Sarah A. Meyer, How-Yi Chang, Adam C. Retchless, Daya N. Marasini et al.
PLoS ONE
Bacterial Infections and Vaccines
article

Characterization of meningococcal disease outbreaks in the United States, 2014–2019

Sarah A. Meyer, How-Yi Chang, Adam C. Retchless, Daya N. Marasini, Amy B Rubis, Lucy A. McNamara, Nicole E. Brown, Gabrielle Cooper, Shalabh Sharma, Caelin Cubenas
article en

Abstract

BACKGROUND: Meningococcal disease, caused by the bacterium Neisseria meningitidis, is a serious bacterial infection that can be fatal or leave survivors with permanent sequelae. Despite decades of declining incidence in the United States (U.S.), meningococcal disease outbreaks are still of public health concern. METHODS: Meningococcal disease cases reported through the National Notifiable Diseases Surveillance System along with additional data provided by jurisdiction health departments were used to identify outbreak-associated cases and public health response measures during 2014-2019. Outbreaks were defined as 2-3 cases within an organization during a 3-month period, an incidence of meningococcal disease above expected in a community during a 3-month period, or ≥2 cases that occurred in the same family or household during a 24-month period. RESULTS: Twenty-nine meningococcal disease outbreaks were reported in the U.S. during 2014-2019 (18 organization, 8 community, 3 household). Outbreak-associated cases (n = 130), accounted for 5.8% of all meningococcal disease cases (n = 2,228) reported during 2014-2019 and were predominantly serogroups B and C. Community outbreaks had longer median durations (203 days) compared to family/household and organization outbreaks (136 days and 9 days, respectively). Of the 7 family/household outbreak-associated cases, only 2 occurred within 14 days of each other. Based on available information for 23 outbreaks, a response measure was implemented in 21 outbreaks: mass vaccination campaign alone (14), expanded chemoprophylaxis alone (2), and both mass vaccination campaign and expanded chemoprophylaxis (5). CONCLUSION: We identified outbreaks of meningococcal disease in a variety of settings and populations; however, this is the first time family/household outbreaks have been systematically characterized in the U.S. Our findings suggest that household contacts of meningococcal disease patients may be at increased disease risk beyond direct secondary transmission. Additional evaluations will be helpful to better assess the potential benefit of vaccination for family members of cases in household settings.

PLoS ONEVol. 21(11)
Centers for Disease Control and Prevention (US), National Center for Immunization and Respiratory Diseases (US), National Center for Emerging and Zoonotic Infectious Diseases (US)
Centers for Disease Control and Prevention
Good health and well-being
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon